The European Commission Approves Chrysanthemum cinerariaefolium Extract for Use in Biocidal Products of Type 18
Context
Under Regulation (EU) No. 528/2012 of the European Parliament and the Council, the European Commission has recently reached a significant milestone by approving the use of Chrysanthemum cinerariaefolium extract. This active substance is derived from mature, open flowers of Tanacetum cinerariaefolium using an advanced technique involving supercritical carbon dioxide. Its approval is intended for use in type 18 biocidal products, marking a significant advancement in the fight against pest insects. This important announcement comes with an effective date set for February 1, 2025.
Evaluation in Compliance with Directive 98/8/EC
This regulatory advancement results from a thorough evaluation of the active substance in compliance with Directive 98/8/EC of the European Parliament and the Council. This directive covers various categories of products, including insecticides, acaricides, and other products designed to combat harmful arthropods. The comprehensive evaluation was conducted by Spain, designated as the rapporteur member state, with the evaluation report submitted to the Commission on September 1, 2010.
Approval Date
The European Commission has set the approval date for Chrysanthemum cineracinerariaefolium riaefolium extract produced using supercritical carbon dioxide from mature, open flowers of Tanacetum cinerariaefolium to be February 1, 2025. This decision aims to enhance the effectiveness of biocidal products in the battle against pest insects, a critical issue for environmental and public health protection.
Compliance Deadline
To allow stakeholders to adapt to the new requirements gradually, a compliance deadline has been carefully established before the approval of this active substance. This will enable industry players to gradually adapt to the new regulations and ensure the safe and responsible use of this potent biocidal substance.
Want to learn more about the approval of Chrysanthemum cinerariaefolium extract? How to prepare an application for product authorization or implement transitional measures for your products containing this active substance?
For more information, please don't hesitate to contact us.
.png)
Context
Under Regulation (EU) No. 528/2012 of the European Parliament and the Council, the European Commission has recently reached a significant milestone by approving the use of Chrysanthemum cinerariaefolium extract. This active substance is derived from mature, open flowers of Tanacetum cinerariaefolium using an advanced technique involving supercritical carbon dioxide. Its approval is intended for use in type 18 biocidal products, marking a significant advancement in the fight against pest insects. This important announcement comes with an effective date set for February 1, 2025.
Evaluation in Compliance with Directive 98/8/EC
This regulatory advancement results from a thorough evaluation of the active substance in compliance with Directive 98/8/EC of the European Parliament and the Council. This directive covers various categories of products, including insecticides, acaricides, and other products designed to combat harmful arthropods. The comprehensive evaluation was conducted by Spain, designated as the rapporteur member state, with the evaluation report submitted to the Commission on September 1, 2010.
Approval Date
The European Commission has set the approval date for Chrysanthemum cineracinerariaefolium riaefolium extract produced using supercritical carbon dioxide from mature, open flowers of Tanacetum cinerariaefolium to be February 1, 2025. This decision aims to enhance the effectiveness of biocidal products in the battle against pest insects, a critical issue for environmental and public health protection.
Compliance Deadline
To allow stakeholders to adapt to the new requirements gradually, a compliance deadline has been carefully established before the approval of this active substance. This will enable industry players to gradually adapt to the new regulations and ensure the safe and responsible use of this potent biocidal substance.
Want to learn more about the approval of Chrysanthemum cinerariaefolium extract? How to prepare an application for product authorization or implement transitional measures for your products containing this active substance?
For more information, please don't hesitate to contact us.
